{"filing":{"accession_number":"0000718937-26-000029","cik":"0000718937","ticker":"STAA","company_name":"STAAR SURGICAL CO","form":"8-K","filing_date":"2026-06-22","report_date":null,"primary_document":"staa-20240620.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/718937/000071893726000029/staa-20240620.htm"},"events":[{"id":12734,"run_id":11298,"accession_number":"0000718937-26-000029","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"STAAR Surgical held its 2026 Annual Meeting of Shareholders and disclosed voting results on four proposals: election of seven directors, approval of Amendment No. 2 to the Amended and Restated Omnibus Equity Incentive Plan (increasing share reserve by 3,900,000 shares), ratification of BDO USA, P.C. as independent auditor, and an advisory vote on executive compensation.","company_name":"STAAR SURGICAL CO","ticker":"STAA","filing_date":"2026-06-22","form":"8-K","submitted_at":null,"items":[{"id":9668,"accession_number":"0000718937-26-000029","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on shareholder approval of Amendment No. 2 to the STAAR Surgical Company Amended and Restated Omnibus Equity Incentive Plan, which increases the share reserve by 3,900,000 shares. This is a compensatory arrangement amendment affecting equity grants available to officers and directors, fitting the exec_compensation category. The material nature is evidenced by the substantial increase in authorized equity and the formal shareholder vote required under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T20:48:09.704800+00:00","company_name":"","ticker":null,"filing_date":""},{"id":9669,"accession_number":"0000718937-26-000029","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from STAAR Surgical's 2026 Annual Meeting, covering four proposals: election of seven directors, approval of equity plan amendment, ratification of auditor (BDO USA, P.C.), and advisory vote on executive compensation. The filing presents final vote tallies with shares for, against, abstain, and broker non-votes for each proposal, which is the standard format for Item 5.07 disclosures and constitutes material information about shareholder actions.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T20:48:09.704800+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":9668,"accession_number":"0000718937-26-000029","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on shareholder approval of Amendment No. 2 to the STAAR Surgical Company Amended and Restated Omnibus Equity Incentive Plan, which increases the share reserve by 3,900,000 shares. This is a compensatory arrangement amendment affecting equity grants available to officers and directors, fitting the exec_compensation category. The material nature is evidenced by the substantial increase in authorized equity and the formal shareholder vote required under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T20:48:09.704800+00:00","company_name":"STAAR SURGICAL CO","ticker":"STAA","filing_date":"2026-06-22"},{"id":9669,"accession_number":"0000718937-26-000029","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from STAAR Surgical's 2026 Annual Meeting, covering four proposals: election of seven directors, approval of equity plan amendment, ratification of auditor (BDO USA, P.C.), and advisory vote on executive compensation. The filing presents final vote tallies with shares for, against, abstain, and broker non-votes for each proposal, which is the standard format for Item 5.07 disclosures and constitutes material information about shareholder actions.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T20:48:09.704800+00:00","company_name":"STAAR SURGICAL CO","ticker":"STAA","filing_date":"2026-06-22"}]}